CompletedPHASE1, PHASE2NCT00004789

Phase I/II Study of Heme Arginate and Tin Mesoporphyrin for Acute Porphyria

Studying Acute hepatic porphyria

Last synced from ClinicalTrials.gov May 8, 2026

ℹ

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.

Report missing data

Key facts

Sponsor: National Center for Research Resources (NCRR)
Principal Investigator: Karl Elmo Anderson
University of Texas
Intervention: heme arginate(drug)
Enrollment: 59 enrolled
Eligibility: 18 years · All sexes
Timeline: 1993

Collaborators

University of Texas

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00004789 on ClinicalTrials.gov

Other trials for Acute hepatic porphyria

Additional recruiting or active studies for the same condition.

ACTIVE NOT RECRUITINGNCT05344599
Evaluating the Prevalence of Acute Hepatic Porphyria in Postural Tachycardia Syndrome
Vanderbilt University Medical Center
RECRUITINGNCT04883905
ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)
Alnylam Pharmaceuticals

See all trials for Acute hepatic porphyria →

← Back to all trials